Code | CSB-RA004848A0HU |
Size | US$210 |
Order now | |
Image |
|
Have Questions? | Leave a Message or Start an on-line Chat |
Application | Recommended Dilution |
---|---|
WB | 1:500-1:5000 |
IF | 1:20-1:200 |
IP | 1:200-1:1000 |
The CCR9 recombinant monoclonal antibody is produced by transfecting the antibody DNA gene-vector clones into the cell line for in vitro expression. The antibody DNA gene encodes a synthesized peptide derived from human CCR9 protein. This CCR9 antibody can react with the CCR9 protein of human- and mouse-origin. It is purified through the affinity-chromatography approach. And it is recommended for ELISA, WB, IF, and IP applications.
CCR9 is mainly distributed in immature T lymphocytes and on the surface of intestinal cells, and it plays a role in T lymphocyte development and tissue-specific homing when bound to its specific and CCL25. CCR9 has been found to be highly expressed in a wide range of cancers and has been linked to tumor chemoresistance and metastasis. It is therefore a potential tumor biomarker in diagnosis and therapy.
There are currently no reviews for this product.